AKESOgen Competitors and Similar CompaniesClear all
AKESOgen's competitors and similar companies include Aceragen, Biothera, Akebia Therapeutics and F-star Biotechnology.
 AKESOgen AKESOgen is a biomarker, genomics and pharmacogenomics contract research organization that services the academic, pharmaceutical, biotechnology and agricultural |  Aceragen Aceragen (formerly known as Idera Pharmaceuticals) is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates. |  Biothera Biothera is a biotechnology company developing natural gluco polysaccharides that engage and direct natural innate immune systems. |  F-star Biotechnology F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology. | ||
Founding Date | Founding Date 2010 | Founding Date 1989 | Founding Date 1997 | Founding Date 2007 | Founding Date 2006 |
Type | Type Subsidiary | Type Public | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Norcross, US HQ | Locations Durham, US HQ | Locations Roseville, US HQ | Locations Cambridge, US HQ | Locations Cambridge, GB HQ Wien, AT Cambridge, US |
Employees | Employees 6 | Employees 3642% decrease | Employees 542% increase | Employees 324187% increase | Employees 39 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 3.2 m | Valuation ($) N/A | Valuation ($) 359.6 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $4.9m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) $236.2m (FY, 2025) | Revenue (est.) £18.7m (FY, 2018) |
Net income | Net income N/A | Net income ($23.4m) (FY, 2022) | Net income N/A | Net income ($5.3m) (FY, 2025) | Net income (£2.6m) (FY, 2018) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 1.6m (over 11 years ago) | Latest funding round N/A | Latest funding round $ 9.4m (over 12 years ago) |
Total funding raised | Total funding raised $ 1.5m | Total funding raised $ 13.8m | Total funding raised $ 5.1m | Total funding raised N/A | Total funding raised $ 57.3m |
For sources of this data, please see the company profile
View Company Profiles
Aceragen
HQ
Durham, US
Employees
36↓ 42% decrease
Aceragen (formerly known as Idera Pharmaceuticals) is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
View companyBiothera
HQ
Roseville, US
Employees
54↑ 2% increase
Biothera is a biotechnology company developing natural gluco polysaccharides that engage and direct natural innate immune systems.
View company
Akebia Therapeutics
HQ
Cambridge, US
Employees
324
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
View companyF-star Biotechnology
HQ
Cambridge, GB
Employees
39
F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.
View company